Global Solid Tumors Drugs Market 2016-2020 - New Study Released

From: Fast Market Research, Inc.
Published: Tue Jul 12 2016

The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors.

Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.

Technavio's analysts forecast the global solid tumors drugs market to grow at a CAGR of 8.6% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global solid tumors drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat solid tumors. It also considers the revenues to be generated from the sales of drugs that are anticipated to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.

Full Report Details at

The market is divided into the following segments based on geography:

* Americas

Technavio's report, Global Solid Tumors Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* F. Hoffmann-La Roche
* Novartis
* Celgene
* Johnson & Johnson
* Pfizer

Other prominent vendors

* AbbVie
* AbGenomics
* ADC Therapeutics
* Advantagene
* Agensys
* Almac Group
* Ambrx
* Argos Therapeutics
* Array BioPharma
* Astellas Pharma
* AstraZeneca
* Bayer
* Biogen
* Biotech Pharmaceutical
* Boehringer Ingelheim
* Boston Biomedical
* Celldex Therapeutics
* Chugai Pharmaceutical
* Cold Genesys
* CTI BioPharma
* Daiichi Sankyo
* DNAtrix
* Ds-Pharma
* Eleison Pharmaceuticals
* Eli Lilly
* Endo Pharmaceuticals
* Formation Biologics
* Fortress Biotech
* Genmab
* Immatics Biotechnologies
* Immunogen
* Immunomedics
* Intas Pharmaceuticals
* Kairos Therapeutics
* Kyowa Hakko Kirin
* MedImmune
* Merck
* Mersana Therapeutics
* Morphotek
* Neovii Biotech
* NewLink Genetics
* Northwest Biotherapeutics
* Novartis
* OncoMed Pharmaceuticals
* Oxford Biotherapeutics
* Peregrine Pharmaceuticals
* Polaris Pharmaceuticals
* Sanofi
* Seattle Genetics

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »